Why the study?
Does human rotavirus vaccine reduce the incidence of severe rotavirus gastroenteritis in African infants?
Does human rotavirus vaccine reduce the incidence of severe rotavirus gastroenteritis in African infants?
Human rotavirus vaccine is effective in reducing severe rotavirus gastroenteritis in African infants during their first year of life.
Supports rotavirus vaccination in African infants; extends efficacy data to high-burden settings.
Human rotavirus vaccine significantly reduced the incidence of severe rotavirus gastroenteritis among African infants during the first year of life. (ClinicalTrials.gov number, NCT00241644.)
No takes yet. Share an insight, caveat, or question.
Madhi et al. (2010) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: